Latest Ratios: P/E Ratio 20.9x · EV/EBITDA 13.7x · ROE 23.3%. (2008–2026 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $225M | $368M | $192M | $133M | $93M | $85M | $101M | $136M | $47M | $47M | $47M |
| Enterprise Value | $205M | $347M | $177M | $117M | $86M | $76M | $89M | $125M | $39M | $40M | $42M |
| P/E Ratio → | 20.89 | 32.54 | 25.57 | 25.91 | 29.75 | 37.08 | 41.81 | 32.74 | 23.70 | 24.64 | 21.27 |
| P/S Ratio | 3.05 | 4.98 | 3.00 | 2.44 | 1.94 | 2.03 | 2.81 | 4.18 | 1.50 | 1.65 | 1.81 |
| P/B Ratio | 4.37 | 6.81 | 4.44 | 2.99 | 2.47 | 2.47 | 3.10 | 4.49 | 1.83 | 2.13 | 2.45 |
| P/FCF | 24.32 | 43.69 | 17.29 | 15.36 | — | — | 38.27 | 42.20 | 39.15 | 24.98 | 92.84 |
| P/OCF | 23.28 | 38.03 | 16.83 | 14.69 | 70.86 | — | 32.70 | 32.37 | 18.16 | 19.13 | 39.28 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.71 | 2.76 | 2.14 | 1.79 | 1.83 | 2.48 | 3.86 | 1.25 | 1.43 | 1.64 |
| EV / EBITDA | 13.68 | 23.21 | 15.99 | 15.80 | 18.61 | 21.23 | 23.68 | 21.41 | 10.46 | 11.53 | 9.80 |
| EV / EBIT | 14.74 | 25.01 | 17.18 | 16.66 | 21.04 | 25.50 | 28.04 | 24.51 | 13.88 | 14.88 | 11.87 |
| EV / FCF | — | 41.27 | 15.93 | 13.52 | — | — | 33.78 | 38.97 | 32.69 | 21.58 | 84.06 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.5% | 78.5% | 78.1% | 76.3% | 76.0% | 75.5% | 76.4% | 77.6% | 76.2% | 76.9% | 79.5% |
| Operating Margin | 18.8% | 18.8% | 15.4% | 12.0% | 8.3% | 7.1% | 8.8% | 15.8% | 9.0% | 9.6% | 13.8% |
| Net Profit Margin | 15.3% | 15.3% | 11.8% | 9.4% | 6.6% | 5.5% | 6.6% | 12.8% | 6.3% | 6.5% | 8.6% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 23.3% | 23.3% | 17.2% | 12.5% | 8.8% | 6.9% | 7.5% | 14.9% | 8.3% | 8.9% | 12.6% |
| ROA | 18.8% | 18.8% | 14.2% | 10.5% | 7.3% | 5.9% | 6.7% | 13.3% | 7.1% | 7.4% | 10.2% |
| ROIC | 33.7% | 33.7% | 26.1% | 16.7% | 10.6% | 9.6% | 11.6% | 20.3% | 12.7% | 13.5% | 19.8% |
| ROCE | 28.5% | 28.5% | 22.5% | 16.0% | 11.1% | 8.9% | 10.0% | 18.3% | 11.9% | 12.9% | 18.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.06 |
| Debt / EBITDA | 0.01 | 0.01 | 0.02 | 0.01 | 0.03 | 0.01 | 0.02 | 0.01 | 0.01 | 0.31 | 0.27 |
| Net Debt / Equity | — | -0.38 | -0.35 | -0.36 | -0.19 | -0.24 | -0.36 | -0.34 | -0.30 | -0.29 | -0.23 |
| Net Debt / EBITDA | -1.36 | -1.36 | -1.37 | -2.15 | -1.56 | -2.25 | -3.15 | -1.77 | -2.07 | -1.81 | -1.02 |
| Debt / FCF | — | -2.41 | -1.36 | -1.84 | — | — | -4.49 | -3.23 | -6.46 | -3.40 | -8.78 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | 53.34 |
Net cash position: cash ($20M) exceeds total debt ($133000)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.69 | 4.69 | 4.31 | 5.75 | 4.69 | 4.83 | 6.83 | 9.38 | 6.78 | 4.68 | 6.38 |
| Quick Ratio | 4.39 | 4.39 | 3.99 | 5.27 | 4.17 | 4.39 | 6.38 | 8.35 | 6.05 | 4.19 | 5.50 |
| Cash Ratio | 1.67 | 1.67 | 1.46 | 2.09 | 0.92 | 1.14 | 2.56 | 3.51 | 2.16 | 1.57 | 1.92 |
| Asset Turnover | — | 1.11 | 1.19 | 1.05 | 1.05 | 1.01 | 0.96 | 0.98 | 1.07 | 1.06 | 1.12 |
| Inventory Turnover | 4.30 | 4.30 | 4.25 | 3.50 | 2.74 | 3.21 | 4.00 | 2.36 | 2.84 | 2.77 | 2.07 |
| Days Sales Outstanding | — | 158.65 | 146.55 | 160.45 | 186.93 | 186.96 | 177.88 | 155.62 | 160.41 | 162.31 | 140.43 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.8% | 3.1% | 3.9% | 3.9% | 3.4% | 2.7% | 2.4% | 3.1% | 4.2% | 4.1% | 4.7% |
| FCF Yield | 4.1% | 2.3% | 5.8% | 6.5% | — | — | 2.6% | 2.4% | 2.6% | 4.0% | 1.1% |
| Buyback Yield | 1.7% | 1.1% | 5.2% | 0.2% | 0.2% | 1.7% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 1.7% | 1.1% | 5.2% | 0.2% | 0.2% | 1.7% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $8M |
Includes 30+ ratios · 19 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ELMD stock.
Electromed, Inc.'s current P/E ratio is 20.9x. The historical average is 32.4x. This places it at the 14th percentile of its historical range.
Electromed, Inc.'s current EV/EBITDA is 13.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.2x.
Electromed, Inc.'s return on equity (ROE) is 23.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 9.6%.
Based on historical data, Electromed, Inc. is trading at a P/E of 20.9x. This is at the 14th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Electromed, Inc. has 78.5% gross margin and 18.8% operating margin. Operating margin between 10-20% is typical for established companies.
Electromed, Inc.'s Debt/EBITDA ratio is 0.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Working capital cash flow swings
Metrics are mathematically derived from official filings.
Returns Double on Margin Alone
ROIC has nearly doubled to 8.7% in 2026Q4 from 4.5% in 2024Q3, and according to ELMD's quarterly ratio disclosures, the improvement traces almost entirely to margin expansion rather than asset efficiency, since asset turnover barely moved from 0.29 to 0.31 over the same ten quarters.
The roughly 420 basis point ROIC gain is essentially a margin story, with operating margin rising from 13.3% to 19.7% while the asset base expanded 35.6% over the period, so the return trajectory appears reversible if the 78.7% gross margin normalizes toward disclosed device-peer levels. Because there is no debt amplifying the equity base, the unusually narrow spread between 8.7% ROIC and 6.6% ROE suggests returns are being generated operationally rather than financially, but the absolute level still looks modest relative to the multiple investors are paying.
Margin Gains Outpace Cash Conversion
Gross margin of 78.7% and operating margin of 19.7% in 2026Q4 both stand at series highs, yet per ELMD's disclosed statements, stock-based compensation of roughly $762K against $3.4M of net income suggests normalized earning power sits a couple of points below the headline 17.5% net margin.
The operating and net margin lines have decoupled positively versus 2024Q3 (13.3% and 10.8% respectively), which implies both genuine overhead leverage and smaller below-the-line drags, making the operating margin the cleaner read of underlying earning power. Investors should nonetheless hold that conclusion loosely, since FCF margin has swung between -0.6% and 30.0% around the same earnings stream, indicating the reported profit levels convert to cash unevenly quarter to quarter.
Working Capital Cycle Compresses 90 Days
The cash conversion cycle has compressed to 160 days in 2026Q4 from 250 days in 2024Q3, and as reported in ELMD's working capital disclosures, the improvement came primarily from inventory days falling from 117 to 77 while receivables still stand at 141 days.
A 141-day receivable position against a 58-day payable cycle means customers rather than suppliers are funding working capital, so reported earnings remain exposed to collection timing, consistent with the $1.9M working capital drag in 2026Q4 despite $3.4M of net income. The low 0.31 asset turnover should be read with judgment: it partly reflects the $20.4M cash balance sitting in the denominator rather than operational sluggishness, so operating-asset turnover would present a more flattering picture.
Debt-Free Structure Limits Ratio Insight
Electromed carries essentially no debt, with debt-to-equity at 0.00 and debt-to-EBITDA of just 0.03 in 2026Q4, while interest coverage is not disclosed in the supplied ratio table, indicating debt service does not appear to constrain current operations.
With no meaningful borrowings, the leverage metrics convey little risk information this cycle, so the analytical question shifts to whether the $20.4M cash balance is earning an adequate return or is dilutive to the 8.7% ROIC. Given coverage data is unavailable, any assessment of future borrowing capacity would need to be constructed directly from the balance sheet rather than inferred from ratios.
Liquidity Buffer Steady Despite Buybacks
Current and quick ratios of 4.69 and 4.39 in 2026Q4 mark a step down from 6.53 and 5.87 in 2024Q3, and based on ELMD's reported balance sheets, cash of $20.4M still exceeds the entire $12.3M liability base by roughly 1.7 times.
The drift downward appears driven by deliberate capital deployment into roughly $14.2M of share repurchases and working capital investment rather than by a swelling obligation profile, so the buffer is shrinking by choice if the disclosed buyback activity is representative of policy. Under a severe stress scenario the 4.39 quick ratio implies near-term claims are covered about 4.4 times over by liquid assets, though the 141-day receivable book would arguably be the first asset to re-price in a downturn.
Valuation Prices In Further Margin Gains
At 31.0x TTM earnings and 18.6x EV/EBITDA, ELMD trades at a premium that compresses to 21.9x forward earnings and 13.8x forward EBITDA, implying the market is pricing continued margin gains rather than the 8.7% ROIC currently being delivered.
The 5.38x price-to-book versus INGN's 1.01x and a PEG of 2.41 suggest pricing reflects margin durability more than growth scarcity, especially since INGN is loss-making at -13.2% ROE and provides no clean earnings multiple for comparison. The roughly 26% step-down from trailing to forward EV/EBITDA embeds an assumption of further EBITDA expansion, a key sensitivity given the 78.7% gross margin sits far above the 47.6% disclosed for the one available peer.
ROE Flattered by Buyback-Shrunken Equity
ROE is the ratio most likely to mislead on ELMD: with zero leverage and $14.2M of buybacks shrinking the equity base, the 3.6%-to-6.6% ROE rise reflects capital return choices as much as operating improvement, per ELMD's disclosed figures.
Because there is no debt to cushion the denominator, management's repurchase decisions mechanically move ROE in either direction independent of profitability, so the doubling of ROE over ten quarters blends real margin gains with capital structure activity and should not be read as pure operating compounding. ROIC of 8.7% read alongside operating margin and FCF margin is the more reliable lens here, since it prevents the cash-heavy, asset-light balance sheet from distorting the assessment of operating performance.